RARA CRAFT DATABASE for FDA Medical Devices
De NovoDEN170047

FDA DEVICE FACTS

Curetis Unyvero LRT Application

Curetis GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATE04/03/2018PRODUCT CODEQBH

Indications for use

T he Unyvero LRT Application is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of nucleic acid sequences from the following microorganisms and antibiotic resistance markers in endotracheal aspirates from adult hospitalized patients with suspected lower respiratory tract infections. Page 2 - Gail Radcliffe DEN170047 Microorganism Associated antibiotic resistance marker Acinetobacter spp. a ctx-M b, kpc, ndm, oxa-23, oxa-24, oxa-58, vim Chlamydia pneumoniae - Citrobacter freundii ctx-M b, kpc, ndm, oxa-48, vim Enterobacter cloacae complex c ctx-M b, kpc, ndm, oxa-48, vim Escherichia coli ctx-M b, kpc, ndm, oxa-48, vim Haemophilus influenzae tem Klebsiella oxytoca ctx-M b, kpc, ndm, oxa-48, vim Klebsiella pneumoniae d ctx-M b, kpc, ndm, oxa-48, vim Klebsiella variicola ctx-M b, kpc, ndm, oxa-48, vim Legionella pneumophila - Moraxella catarrhalis - Morganella morganii ctx-M b, kpc, ndm, oxa-48, vim Mycoplasma pneumoniae - Proteus spp. e ctx-M b, kpc, ndm, oxa-48, vim Pseudomonas aeruginosa ctx-M b, kpc, ndm, vim Serratia marcescens ctx-M b, kpc, ndm, oxa-48, vim Staphylococcus aureus mecA Stenotrophomonas maltophilia - Streptococcus pneumoniae -a Acinetobacter spp. includes: A. baumannii, A. calcoaceticus, A. haemolyticus, A. junii, A. lwoffii, A. nosocomialis, A. parvus, A. pittii, (detected by LRT Application) and A. ursingii (not detected by LRT Application). b ctx-M1 subgroup. c Enterobacter cloacae complex includes: E. asburiae, E. cloacae, E. hormaechei, E. kobei, E. ludwigii, and

E. xiangfangensis. d Klebsiella pneumoniae includes two variants: K. pneumoniae (variant 1), and K. quasipneumoniae (variant 2) e Proteus spp. includes P. hauseri, P. mirabilis, P. penneri and P. vulgaris. The Unyvero LRT Application performed on the Unyvero System is indicated as an aid in the diagnosis of lower respiratory tract infection in adult hospitalized patients with signs and symptoms of lower respiratory infection; results should be used in conjunction with other clinical and laboratory findings. As tracheal aspirates commonly contain colonizing microorganisms, detection of Unyvero LRT microbial targets does not indicate that the microorganism is the cause of the disease. Unyvero positive results do not rule out co-infection with microorganisms not detected by the Unyvero LRT Application. Negative results do not preclude lower respiratory infection, as the causative agent may be a microorganism not detected by this test. A negative result for any antibiotic resistance marker does not indicate that detected microorganisms are susceptible to applicable antimicrobial agents. Detected resistance markers cannot be definitively linked to specific microorganisms, and may be present in organisms that are not detected by the Unyvero LRT Application such as organisms present as colonizing or normal flora. M icrobiology cultures of aspirates should be performed to obtain isolates for species identification and antimicrobial susceptibility testing, to differentiate quantities of identified microorganisms as well as normal flora present in the specimen and to identify potential microorganisms not targeted by Page 3 - Gail Radcliffe DEN170047 the Unyvero LRT Application.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026